GlycoMantra has been awarded a two-year SBIR Phase 2 grant ($3.7 M) from the NIDDK…
GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)
GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.
Blog
GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.